Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin Luis S. Noble, M.D., William H. Kutteh, M.D., Ph.D., Nanette Lashey, M.D., Rodney D. Franklin, B.S., Juan Herrada, M.D. Fertility and Sterility Volume 83, Issue 3, Pages 684-690 (March 2005) DOI: 10.1016/j.fertnstert.2004.11.002 Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions
FIGURE 1 Allocation of patients with recurrent pregnancy loss and antiphospholipid antibodies to treatment groups. LMWH = low-molecular-weight heparin; UFH = unfractionated heparin; LDA = low dose aspirin (81 mg). Fertility and Sterility 2005 83, 684-690DOI: (10.1016/j.fertnstert.2004.11.002) Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions